Dominique Milea

754 total citations
32 papers, 522 citations indexed

About

Dominique Milea is a scholar working on Pharmacology, Social Psychology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dominique Milea has authored 32 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Social Psychology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dominique Milea's work include Treatment of Major Depression (11 papers), Mental Health Treatment and Access (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Dominique Milea is often cited by papers focused on Treatment of Major Depression (11 papers), Mental Health Treatment and Access (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Dominique Milea collaborates with scholars based in France, United States and China. Dominique Milea's co-authors include Mondher Toumi, Delphine Saragoussi, Florent Guelfucci, Ylana Chalem, Jean‐Paul Auray, Patrice Verpillat, Lene Hammer-Helmich, Jae Min Kim, Jin Pyo Hong and Benoît Rive and has published in prestigious journals such as Journal of the American Geriatrics Society, Psychiatry Research and BMJ Open.

In The Last Decade

Dominique Milea

31 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Milea France 13 178 163 112 97 92 32 522
Rym Ben-Hamadi United States 12 133 0.7× 181 1.1× 85 0.8× 134 1.4× 146 1.6× 29 791
N. Dantchev France 12 196 1.1× 212 1.3× 165 1.5× 99 1.0× 70 0.8× 29 796
Patricia Mottram United Kingdom 11 209 1.2× 262 1.6× 62 0.6× 123 1.3× 94 1.0× 16 669
Alessa von Wolff Germany 14 192 1.1× 110 0.7× 165 1.5× 77 0.8× 108 1.2× 25 619
Jan A. Swinkels Netherlands 9 203 1.1× 192 1.2× 81 0.7× 88 0.9× 142 1.5× 17 541
Suzanne L West United States 6 121 0.7× 184 1.1× 72 0.6× 91 0.9× 54 0.6× 9 437
K.M.L. Huijbregts Netherlands 12 117 0.7× 109 0.7× 97 0.9× 201 2.1× 105 1.1× 17 443
Rita Prieto Spain 13 124 0.7× 124 0.8× 145 1.3× 69 0.7× 95 1.0× 34 749
Ilse R. Wiechers United States 14 84 0.5× 151 0.9× 84 0.8× 77 0.8× 104 1.1× 39 651
Judith Strobl United Kingdom 8 95 0.5× 132 0.8× 143 1.3× 49 0.5× 78 0.8× 11 501

Countries citing papers authored by Dominique Milea

Since Specialization
Citations

This map shows the geographic impact of Dominique Milea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Milea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Milea more than expected).

Fields of papers citing papers by Dominique Milea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Milea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Milea. The network helps show where Dominique Milea may publish in the future.

Co-authorship network of co-authors of Dominique Milea

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Milea. A scholar is included among the top collaborators of Dominique Milea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Milea. Dominique Milea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Shih-Lung, Shu‐Min Lin, Chung‐Kan Peng, et al.. (2025). A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT). Therapeutic Advances in Respiratory Disease. 19. 2693887734–2693887734. 3 indexed citations
2.
Yap, Desmond Y. H., et al.. (2024). Long-Term Kidney Outcome of Lupus Nephritis by Renal Response Status. Kidney International Reports. 9(12). 3532–3541. 2 indexed citations
3.
Lam, Shao Wei, Mariko Siyue Koh, Sumitra Shantakumar, et al.. (2023). Development of a real-world database for asthma and COPD: The SingHealth-Duke-NUS-GSK COPD and Asthma Real-World Evidence (SDG-CARE) collaboration. BMC Medical Informatics and Decision Making. 23(1). 4–4. 5 indexed citations
4.
5.
Lee, Chang‐Hoon, Mi‐Sook Kim, Chin Kook Rhee, et al.. (2022). Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea. Respiratory Research. 23(1). 231–231. 3 indexed citations
6.
Milea, Dominique, et al.. (2021). A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand. International Journal of COPD. Volume 16. 1835–1850. 8 indexed citations
7.
8.
Knapp, Martín, Kia‐Chong Chua, Matthew Broadbent, et al.. (2016). Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register. BMJ Open. 6(11). e013591–e013591. 68 indexed citations
9.
10.
Yu, Xin, Shengdi Chen, Xiaochun Chen, et al.. (2015). Clinical management and associated costs for moderate and severe Alzheimer’s disease in urban China: a Delphi panel study. Translational Neurodegeneration. 4(1). 15–15. 17 indexed citations
11.
Chalem, Ylana, et al.. (2014). Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea: Results of Perform-K. Value in Health. 17(7). A766–A767. 1 indexed citations
12.
Low, Wah Yun, et al.. (2014). Comparative Pharmacoeconomics Studies of Treatment for Major Depressive Disorder in China. Value in Health. 17(7). A769–A769. 1 indexed citations
13.
Clay, E., et al.. (2014). The Growing Challenge Of Managing Age-Related Diseases In China: Example Of Alzheimer’s Disease. Value in Health. 17(3). A65–A65. 1 indexed citations
14.
Low, Wah Yun, et al.. (2014). Prevalence of Major Depressive Disorder in China. Value in Health. 17(7). A767–A767. 3 indexed citations
15.
Saragoussi, Delphine, Josep María Haro, J.P. Boulenger, et al.. (2013). Patient-Reported Cognitive Dysfunction Negatively Impacts Functioning in Patients with Major Depressive Disorder – Preliminary Findings from the Perform Study. Value in Health. 16(7). A543–A544. 7 indexed citations
16.
Saragoussi, Delphine, et al.. (2012). Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study. International Journal of Clinical Practice. 66(11). 1079–1087. 24 indexed citations
17.
Salvà, Antoni, et al.. (2012). PND20 12-Month Cost of Illness Study of Moderate Alzheimer'S Disease Patients in Spain: The Evocost Study. Value in Health. 15(7). A549–A549. 1 indexed citations
18.
Saragoussi, Delphine, et al.. (2011). Comparing Antidepressant Treatment Patterns in Older and Younger Adults: A Claims Database Analysis. Journal of the American Geriatrics Society. 59(7). 1197–1205. 27 indexed citations
19.
Kunz, Dieter, et al.. (2011). Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Expert Opinion on Pharmacotherapy. 13(1). 9–16. 24 indexed citations
20.
Milea, Dominique, Patrice Verpillat, Florent Guelfucci, Mondher Toumi, & Michel Lamure. (2010). Prescription patterns of antidepressants: findings from a US claims database. Current Medical Research and Opinion. 26(6). 1343–1353. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rym Ben-Hamadi Breakdown of academic impact, for papers by N. Dantchev Breakdown of academic impact, for papers by Patricia Mottram Breakdown of academic impact, for papers by Alessa von Wolff Breakdown of academic impact, for papers by Jan A. Swinkels Breakdown of academic impact, for papers by Suzanne L West Breakdown of academic impact, for papers by K.M.L. Huijbregts Breakdown of academic impact, for papers by Rita Prieto Breakdown of academic impact, for papers by Ilse R. Wiechers Breakdown of academic impact, for papers by Judith Strobl
Rankless by CCL
2026